CDK5-IN-4
CDK5-IN-4 (compound 4) is a potent multikinase type-II inhibitor targeting CDK5, with an IC50 of 9.8 μM. CDK5-IN-4 also inhibits GSK-3α, GSK-3β, CDK9, and CDK2, with IC50 values of 0.98, 4.00, 1.76, and 6.24 μM, respectively. CDK5-IN-4 can be used for glioblastoma research[1].
Product Specifications
CAS Number
1212711-91-5
UNSPSC
12352005
Target
CDK; GSK-3
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk5-in-4.html
Smiles
O=C(N[C@H]1CO[C@@H]2[C@H](CO[C@H]12)NC3=NC(C4=CC=CC(F)=C4)=CC=N3)NCC5=CC=CC=C5
Molecular Formula
C24H24FN5O3
Molecular Weight
449.48
References & Citations
[1]Khan ZR, et al. Discovery of Potent Multikinase Type-II Inhibitors Targeting CDK5 in the DFG-out Inactive State with Promising Potential against Glioblastoma. J Med Chem. 2024 Apr 30.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2; CDK5; CDK9; GSK-3α; GSK-3β
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880968-500 1x 500 µL
CD63 (LAMP3/968), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042754-500 1x 500 µL
CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (CR2/2754), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401274-500 1x 500 µL
Cytokeratin 10 (Suprabasal Epithelial Marker) (AE20), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 